Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: szentecyclolabhu

June 17, 2026 Life sciences / Pharma applications

Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths

Molecular-order-related membrane biophysical properties contribute to the functional modulation of transmembrane proteins, and therefore, their changes due to a modified

Continue reading

March 30, 2026 CD derivatives

Arthur Lütringhaus, Godfather of catenanes was born 120 years ago

Professor Arthur Lütringhaus is the pioneer of the chemistry of interlocked supramolecular systems, that he named catenates. Arthur Lüttringhaus (1906-1992)

Continue reading

February 6, 2026 CD derivatives / Other industrial use

Blue Danube PhD Symposium – BDSHC 2026

On Friday, the 13th February at 13:30 CET a group of brilliant PhD students from the Blue Danube countries (A,CZ,H, SK,

Continue reading

February 5, 2026 Drug delivery / Pharma applications

Remdesivir (GS-5734) protects African green monkeys (AGM) from Nipah virus challenge

Introduction: Nipah virus is an emerging pathogen in the Paramyxoviridae family, which appers today a real threat for eventual pandemy.

Continue reading

January 9, 2026 CD as API / Pharma applications

Hydroxypropyl-Beta-Cyclodextrin (HPBCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics

A multi-year scientific collaboration between Brasilian and American scientists from Federal University at Rio de Janeiro, Brazil, Laboratory of Immunoregulation,

Continue reading

November 25, 2025 Drug delivery / Pharma applications

Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment

In a recent study, Professors Bodor and Buchwald review the use of cyclodextrin-enabled formulations to develop oral tablets of cladribine

Continue reading

October 13, 2025 CD as API / Pharma applications

JIC Venture Growth Investments Invests in Beren Therapeutics P.B.C. to Advance Innovative, Cyclodextrin-based Therapeutics

JIC Venture Growth Investments (VGI) announced that it has invested in Beren Therapeutics P.B.C. (“Beren Therapeutics”). Beren Therapeutics is developing

Continue reading

September 11, 2025 Drug delivery / Pharma applications

Multiple therapeutic benefits of Sulforaphane/alpha-cyclodextrin complex

Introduction: Sulforaphane (SFN) is a naturally occurring isothiocyanate (Fig.1) associated with various health benefits, including reduced cancer risk, and has

Continue reading

September 2, 2025 Drug delivery / Pharma applications

Selecting a non-interacting buffer for α-cyclodextrin containing solutions

The article examines the effects of twelve pharmaceutically relevant buffers on the inclusion complex between α-cyclodextrin (α-CD) and 1,9-nonanediol using

Continue reading

August 11, 2025 CD as API / Pharma applications

Sickle cell anemia and cyclodextrins

(The very first report on the beneficial consequence of cyclodextrin-assisted cholesterol removal from red blood cell membranes.) Sickle cell anemia

Continue reading

Posts pagination

1 2 3 … 7 Next Posts»

Recent Posts

  • In Vitro and Ex Vivo Studies on the Absorption and Distribution of β-Cyclodextrin Polymer
  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • Impact of Cholesterol Depletion by methyl BCD on Dopamine Transmission Dynamics in Brain
  • Special Issue “Cyclodextrin-Functionalized Materials for Drug Delivery, Pharmaceutical and Medical Applications”
  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (72)
  • CD as API (351)
  • CD derivatives (424)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (804)
  • E-ducation (63)
  • Environmental (141)
  • Events (236)
  • Food (229)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (409)
  • Other industrial use (110)
  • Pharma applications (1,202)
  • Supramolecular systems (44)
  • Uncategorized (161)

Top Posts

  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal
  • In Vitro and Ex Vivo Studies on the Absorption and Distribution of β-Cyclodextrin Polymer
  • CDs for the removal of PFAS; A review
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • How air fresheners work?
  • Use of odor-absorbing component, Hydroxypropyl-β-cyclodextrin in a new Japanese personal care product
  • Impact of Cholesterol Depletion by methyl BCD on Dopamine Transmission Dynamics in Brain
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • The Impact and Prospects of Green Chemistry for Textile Technology
  • Published compilation of the list of approved cyclodextrin-containing drug products

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...